OTAK
Live / Applied — First extension granted (statement of use) (as of 22 Jan 2026)
What this means for you
Not registered yet, but its 09 Apr 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99129228
- Mark type
- Stylized text
- Filed
- 09 Apr 2025
- Published for opposition
- 07 Oct 2025
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Development of pharmaceutical preparations and medicines; Pharmaceutical research in the field of dermatological disorders, including inflammatory skin diseases and chronic skin conditions
Owner
- OTAK PHARMACEUTICAL, LLC, VANCOUVER, WA, US
- OTAK PHARMACEUTICAL, LLC, VANCOUVER, WA, US
Prosecution history
- 23 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jan 2026 — SOU EXTENSION 1 GRANTED
- 22 Jan 2026 — SOU EXTENSION 1 FILED
- 22 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 02 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Oct 2025 — PUBLISHED FOR OPPOSITION
- 01 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Sept 2025 — ASSIGNED TO EXAMINER
- 11 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 09 Apr 2025 — APPLICATION FILING RECEIPT MAILED
- 09 Apr 2025 — NEW APPLICATION ENTERED